Chile’s central bank president drove home the institution’s hawkish message on Thursday, even as she recognized that the highest borrowing costs in more than two decades were set to slow stubborn core inflation.
Germany approved a Polish request for permission to re-export five MiG 29 fighter jets from former East German military stocks to Ukraine.
Vice President Kamala Harris denounced a federal appeals court ruling that will allow restrictions on the widely-used abortion pill mifepristone and restated the White House’s commitment to protecting abortion rights.
Mpox, the smallpox-related infection that exploded in 2022, was linked to 38 US deaths over the past year, most of them among young Black men, who also received vaccines at low rates.
In the frantic hours after Credit Suisse Group AG’s collapse wiped out $17 billion of the firm’s riskiest bonds, investors pored through the fine print of similar bank notes across the globe. Where, they wanted to know, did the contract language closely resemble that in Switzerland, where regulators shocked the market by writing down their investment to zero.
After the FDIC brokered the sale of collapsed Silicon Valley Bank to First Citizens BancShares Inc. — driving up the buyer’s stock price and saddling the regulator with a $20 billion bill — it got a notable critic: one of its own board members.
A private equity consortium backed by CVC Capital Partners is in talks about a potential acquisition of Middle Eastern credit card processor Network International Holdings Plc.
The owner of English Premier League club Leeds United is considering a bid for Inter Milan, one of Italy’s most storied football teams and worth an estimated €1 billion ($1.1 billion).
As far as drug companies go, abortion-pill maker Danco Laboratories is all but anonymous. It has fewer than 20 employees, uses a P.O. Box to avoid sharing its headquarters address and isn’t listed on any public exchanges.
Teck Resources Ltd. has suffered a blow to its plans to separate its coal and metals operations after a major advisory firm urged shareholders to reject the move, complicating its fight to thwart a $23 billion takeover from Glencore Plc.
